According to a market report by Lucintel, the future of the cell analysis market looks promising with opportunities in pharmaceutical & biotechnology companies, hospitals and clinical testing laboratories, and academic and research institutes. The global cell analysis market is expected to reach an estimated $31.7 billion by 2028 with a CAGR of 9.4% from 2023 to 2028. The major drivers for this market are rising prevalence of chronic diseases along with an increase in the demand for personalised medicine for private and convenient treatment methods.
In this market, flow cytometry, PCR, cell microarrays, microscopy, spectrophotometry, and high content screening are the major segments by technique. Lucintel forecasts that flow cytometry will remain the largest technique segment over the forecast period because of its capability to measure the multiple parameters in diverse samples at single-cell levels.
Within this market, pharmaceutical & biotechnology companies are expected to remain the largest end use industry segment due to the growing use of cell analysis as a standard tool and consumable at different phases of drug discovery and development.
North America will remain the largest region due to increasing awareness of personal healthcare, presence of multiple government funding programs, and availability of affordable drugs in the region.
Danaher, Thermo Fisher Scientific, Becton, Dickinson and Company, General Electric, and Merck KGaA are the major suppliers in the global cell analysis market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global cell analysis market by product & service, technique, process, end use industry, and region. Lucintel has compiled a comprehensive research report entitled “Growth Opportunities in the Global Cell Analysis Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global cell analysis market by product & service, technique, process, end use industry, and region, as follows:
Cell Analysis Market by Product & Service [Value ($B) Shipment Analysis from 2017 to 2028]:
Reagents & Consumables
Instruments
Accessories
Software
Service
Cell Analysis Market by Technique [Value ($B) Shipment Analysis from 2017 to 2028]:
Flow Cytometry
PCR
Cell Microarrays
Microscopy
Spectrophotometry
High Content Screening
Others
Cell Analysis Market by Process [Value ($B) Shipment Analysis from 2017 to 2028]:
Cell Identification
Cell Viability
Cell Signaling Pathways/Signal Transduction
Cell Proliferation
Cell Counting and Quality Control
Cell Interaction
Cell Structure Study
Target Identification and Validation
Single-Cell Analysis
Cell Analysis Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
Pharmaceutical & Biotechnology Companies
Hospitals and Clinical Testing Laboratories
Academic and Research Institutes
Others
Cell Analysis Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at
helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global
Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis,
Growth Consulting, M&A, and
Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit
www.lucintel.com.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the cell analysis market by product & service (reagents & consumables, instruments, accessories, software, and service), technique (flow cytometry, PCR, Cell microarrays, microscopy, spectrophotometry, high content screening, and others), process (cell identification, cell viability, cell signaling pathways/signal transduction, cell proliferation, cell counting and quality control, cell interaction, cell structure study, target identification and validation, and single-cell analysis), end use industry (pharmaceutical & biotechnology companies, hospitals and clinical testing laboratories, academic and research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?